PM360

MAY 23, 2024

Bryan Johnson Senior Director, Product Management, Compass Prescriber Veeva Systems Paving the Way to Faster Treatment Starts Bryan’s exposure to life sciences started at a young age, watching his father’s career at companies like Johnson & Johnson and emerging biopharmas. As rare diseases affect about 1 in 10 people in the U.S.,

Retail 52

Retail Biopharma Prescription Healthcare Provider 52

Clarivate

APRIL 18, 2024

In 2024, watch as the global trendsetter brings to bear its technological expertise combined with a captive Prime membership, brand recognition, and national employer buy-in to re-envision healthcare that truly works around the patient. Healthcare segment) across the nation as part of a $1 billion cost-cutting strategy.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

SEPTEMBER 11, 2024

Though there is no cure for the disease, people with Alzheimer’s can receive personalized, multimodal care and support to delay deterioration of their functional status and quality of life and alleviate the burden imposed on their care partners (Emblad, 2021; Bayly, 2021; Xiang, 2024). Food and Drug Administration, 2023 and 2024).

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

PM360

MAY 21, 2024

“Streaming video provides life sciences advertisers with an efficient and effective way to reach patients at any stage of treatment and can help advance their patient marketing efforts.” Biopharma marketers are following their audiences and investment in this channel continues to increase.

Media 105

Media Healthcare Healthcare Marketing 105

Clarivate

SEPTEMBER 5, 2024

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ).

Insurance 52

Insurance Marketing Manufacturing Prescription 52

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. With this in mind, our efforts to reach these people should focus on providing answers, information, and hope—with all the necessary caveats. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

PM360

APRIL 22, 2024

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.

Education 59

Education Physicians Healthcare Healthcare 59